[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624622":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":38,"centralContacts":43,"locations":53,"responsibleParty":68,"collaborators":26,"id":70,"slug":26,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":26,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":90,"overallStatus":92,"whyStopped":26,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8,15],{"label":9,"type":6,"description":10,"interventionNames":11},"Case","Patient with a Lipodystrophy Familial Partial due to a known pathogenic variant of the LMNA gene",[12,13,14],"Genetic: Genetic analysis","Other: Biological analysis","Other: imaging test",{"label":16,"type":6,"description":17,"interventionNames":18},"Control","Patient consulting for polycystic ovary syndrome in day hospital matched on age +\u002F-5 years and BMI+\u002F-5 kg\u002Fm2",[19],"Other: Standard intervention",[21,27,31,35],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"GENETIC","Genetic analysis","Analyses of the insulin resistance and lipodystrophy gene panel revealed pathogenic or highly susceptible variants in control PCOS patients",[9],null,{"type":6,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Biological analysis","Measurement of adipokines",[9],{"type":6,"name":32,"description":33,"armGroupLabels":34,"otherNames":26},"imaging test","DEXA (Dual-Energy X-ray Absorptiometry)",[9],{"type":6,"name":36,"description":36,"armGroupLabels":37,"otherNames":26},"Standard intervention",[16],[39],{"name":40,"affiliation":41,"role":42},"Sophie LAMOTHE","APHP","PRINCIPAL_INVESTIGATOR",[44,50],{"name":45,"role":46,"phone":47,"phoneExt":48,"email":49},"Sophie LAMOTHE, Doctor","CONTACT","0149282406","+33","sophie.lamothe@aphp.fr",{"name":51,"role":46,"phone":47,"phoneExt":48,"email":52},"Camille VATIER, Doctor","camille.vatier@aphp.fr",[54],{"facility":55,"status":26,"city":56,"state":26,"zip":57,"country":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":65},"Service Endocrinologie, Hôpital St Antoine","Paris","75012","France",{"type":60,"coordinates":61},"Point",[62,63],2.3488,48.85341,{"lat":63,"lon":62},[66,67],{"name":45,"role":46,"phone":47,"phoneExt":48,"email":49},{"name":51,"role":46,"phone":47,"phoneExt":48,"email":52},{"type":69,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100624622",false,"NCT07412028","Identification of Women With Severe Insulin Resistant Syndromes of Genetic Origin Among Patients With \"Classic\" Polycystic Ovary Syndrome (PCOS)","ANDROLIPO","Inclusion Criteria:\n\n* Women aged ≥ 18 years and \\\u003C 45 years ;\n* Discontinuation of estrogen-progestin therapyfor at least 3 months ;\n* Signed informed consent ;\n* Social security affiliation.\n\nCase (n=25):\n\n\\- Patient with a lipodystrophic syndrome due to a known pathogenic variant of the LMNA gene.\n\nControl (n=50), :\n\n\\- patient consulting for polycystic ovary syndrome (PCOS according to the Rotterdam criteria) in day hospital matched on age +\u002F-5 years and BMI+\u002F-5 kg\u002Fm2.\n\nExclusion Criteria:\n\n* \\- Severe renal insufficiency (GFR \\\u003C 30 ml\u002Fmin) ;\n* Hepato-cellular insufficiency (TP \\\u003C 50%) ;\n* Taking corticosteroids or antiretrovirals ;\n* Menopausal women ;\n* Taking estrogen-progestin therapy;\n* Diabetic patients on insulin : type 1 diabetes or pancreatectomised patients\n* Other known causes of hyperandrogenism (21-hydroxylase block, Cushing's syndrome, ovarian tumor).\n* Pregnant woman\n* Breastfeeding woman","FEMALE","18 Years","45 Years",{"count":80,"type":81},81,"ESTIMATED","INTERVENTIONAL",[84],"NA","Diagnostic case-control study (1 case for 2 controls). Inclusion of patients with severe insulin resistance syndrome of genetic origin, then inclusion of controls: patients examined for PCOS in day hospital with matching age (+\u002F- 5 years) and Body mass index (+\u002F- 5kg\u002Fm2).",[87,88,89],"Polycystic Ovary Syndrome","Familial Partial Lipodystrophy","LMNA (LaMin Nuclear A) Related Disorders",[87,88,91],"LMNA related disorders","NOT_YET_RECRUITING","2026-02-13",{"date":95,"type":96},"2026-02-17","ACTUAL",{"date":98,"type":81},"2026-02",{"date":100,"type":81},"2027-09",{"name":5,"class":6},1]